Nuclear hormone receptors and cholesterol trafficking: The orphans find a new home

Journal of Molecular Medicine

Volumn 80, Issue 5, 2002, Pages 271-281

  Fitzgerald, Michael L ^a   Moore, Kathryn J ^a   Freeman, Mason W ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

ABCA1; Bile acids; Cholesterol absorption; Liver X receptor; Orphan receptors

Indexed keywords

ABC TRANSPORTER; BILE ACID; CHOLESTEROL; FARSENOID X RECEPTOR; HIGH DENSITY LIPOPROTEIN; HORMONE RECEPTOR; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RETINOID X RECEPTOR; STEROL; UNCLASSIFIED DRUG; CELL RECEPTOR; TRANSCRIPTION FACTOR;

BILE ACID METABOLISM; CATABOLISM; CELL LEVEL; CELL MEMBRANE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CYTOLOGY; DRUG TARGETING; GENE CONTROL; GENETICS; IN VIVO STUDY; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MOLECULAR BIOLOGY; NONHUMAN; PHYSIOLOGY; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; STEROL METABOLISM; TRANSCRIPTION REGULATION; ANIMAL; BIOLOGICAL MODEL; HUMAN; METABOLISM;

ANIMAL; ATP-BINDING CASSETTE TRANSPORTERS; BILE ACIDS AND SALTS; HUMAN; MODELS, BIOLOGICAL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; ANIMALS; HUMANS;

EID: 0036012793     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-001-0318-y     Document Type: Review

References (70)

1. A receptor-mediated pathway for cholesterol homeostasis
2. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
3. The nuclear receptor superfamily: The second decade
4. An inventory of the human ABC proteins
5. The RXR heterodimers and orphan receptors
6. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha
7. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway
8. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta
9. Identification of a nuclear receptor for bile acids
10. Bile acids: Natural ligands for an orphan nuclear receptor
11. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer
12. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR
13. Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation
14. Disruption of cholesterol 7alpha-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7alpha-hydroxylase
15. Oxysterols: Modulators of cholesterol metabolism and other processes
16. Bile acid biosynthesis
17. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis
18. 27-Hydroxycholesterol is an endogenous ligand for LXR in cholesterol-loaded cells
19. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha
20. Nuclear orphan receptors control cholesterol catabolism
21. Identification of a nuclear receptor that is activated by farnesol metabolites
22. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
23. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors
24. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
25. ABC transporters in lipid transport
26. Biochemistry of multidrug resistance mediated by the multidrug transporter
27. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
28. Phosphatidylcholine translocase: A physiological role for the mdr2 gene
29. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver
30. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis
31. Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis
32. HDL-cholesterol as a marker of coronary heart disease risk: The Quebec cardiovascular study
33. Tangier disease (familial high density lipoprotein deficiency). Clinical and genetic features in two adults
34. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease
35. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients
36. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
37. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
38. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
39. The Tangier disease gene product ABC1 controls the cellular apoli-poprotein-mediated lipid removal pathway
40. Novel mutations in the gene encoding ATP-binding cassette 1 in four Tangier disease kindreds
41. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size
42. ATP-binding cassette transporter A1 contains an NH2-terminal signal anchor sequence that translocates the protein's first hydrophilic domain to the exoplasmic space
43. Cloning of two novel ABC transporters mapping on human chromosome 9
44. ABC1, an ATP binding cassette transporter required for phagocytosis of apoptotic cells, generates a regulated anion flux after expression in Xenopus laevis oocytes
45. Membrane topology of the atp binding cassette transporter abcr and its relationship to abc1 and related abca transporters. Identification of n-linked glycosylation sites
46. Homogeneous assay based on 52 primer sets to scan for mutations of the ABCA1 gene and its application in genetic analysis of a new patient with familial high-density lipoprotein deficiency syndrome
47. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1
48. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages
49. Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter
50. Atp-binding cassette transporter a1 (abca1) functions as a cholesterol efflux regulatory protein
51. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport
52. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols
53. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters
54. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption
55. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors
56. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): Evidence for sterol-dependent regulation in macrophages
57. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines
58. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor
59. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
60. ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism
61. Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL
62. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha
63. Ppargamma: A nuclear regulator of metabolism, differentiation, and cell growth
64. PPARg promotes monocyte/macrophage differentiation and uptake of oxidized LDL
65. The role of PPAR-gamma in macrophage differentiation and cholesterol uptake
66. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
67. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
68. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
69. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport
70. Peroxisome proliferator-activated receptors in macrophage biology: Friend or foe?